CoChat

Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance

Open access
Verduzco, Daniel, Lloyd, Mark, Xu, Liping, Ibrahim-Hashim, Arig, Balagurunathan, Yoganand, Gatenby, Robert A., Gillies, Robert J. · 2015 · PLOS ONE
Cited by 75

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Hypoxia in tumors correlates with greater risk of metastases, increased invasiveness, and resistance to systemic and radiation therapy. The evolutionary dynamics that links specific adaptations to hypoxia with these observed tumor properties have not been well investigated. While some tumor populations may experience fixed hypoxia, cyclical and stochastic transitions from normoxia to hypoxia are commonly observed in vivo. Although some phenotypic adaptations to this cyclic hypoxia are likely reversible, we hypothesize that some adaptations may become fixed through mutations promoted by hypoxia-induced genomic instability. Here we seek to identify genetic alterations and corresponding stable phenotypes that emerge following cyclic hypoxia. Although these changes may originate as adaptations to this specific environmental stress, their fixation in the tumor genome may result in their observation in tumors from regions of normoxia, a condition known as pseudohypoxia. We exposed several epithelial cell lines to 50 cycles of hypoxia-normoxia, followed by culture in normoxia over a period of several months. Molecular analyses demonstrated permanent changes in expression of several oncogenes and tumor-suppressors, including p53, E-cadherin, and Hif-1α. These changes were associated with increased resistance to multiple cytotoxins, increased survival in hypoxia and increased anchorage-independent growth. These results suggest cycles of hypoxia encountered in early cancers can select for specific and stable genotypic and phenotypic properties that persist even in normoxic conditions, which may promote tumor progression and resistance to therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0120958

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 50

  1. D Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  2. RA Gatenby, 2008, A microenvironmental model of carcinogenesis, Nature reviews, 8, 56
  3. GH Fletcher, 1984, Radiation and drug resistance of breast cancer, Am J Clin Oncol, 7, 617, 10.1097/00000421-198412000-00007 · DOI
  4. J Zhou, 2006, Tumor hypoxia and cancer progression, Cancer Lett, 237, 10, 10.1016/j.canlet.2005.05.028 · DOI · Paper page
  5. M Hockel, 2001, Biological consequences of tumor hypoxia, Biological consequences of tumor hypoxia, 28, 36
  6. CA Aktipis, 2011, Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research, PLOS One, 6, e26100, 10.1371/journal.pone.0026100 · DOI
  7. JW Wojtkowiak, 2011, Drug resistance and cellular adaptation to tumor acidic pH microenvironment, Mol Pharm, 8, 2032, 10.1021/mp200292c · DOI · Paper page
  8. S Cardaci, 2012, TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State, International journal of cell biology, 2012, 161837, 10.1155/2012/161837 · DOI · Paper page
  9. MG Cattaneo, 2011, Chronic deficiency of nitric oxide affects hypoxia inducible factor-1alpha (HIF-1alpha) stability and migration in human endothelial cells, PLOS One, 6, e29680, 10.1371/journal.pone.0029680 · DOI
  10. RS Bindra, 2005, Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis, Mutat Res, 569, 75, 10.1016/j.mrfmmm.2004.03.013 · DOI · Paper page
  11. M Gerlinger, 2012, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N Engl J Med, 366, 883, 10.1056/NEJMoa1113205 · DOI · Paper page
  12. C Bayer, 2012, Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences, Strahlenther Onkol, 188, 616, 10.1007/s00066-012-0085-4 · DOI
  13. CC Wykoff, 2000, Hypoxia-inducible expression of tumor-associated carbonic anhydrases, Cancer Res, 60, 7075
  14. R Airley, 2001, Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix, Clin Cancer Res, 7, 928
  15. G Helmlinger, 1997, Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation, Nature medicine, 3, 177, 10.1038/nm0297-177 · DOI · Paper page
  16. MW Dewhirst, 1996, Microvascular studies on the origins of perfusion-limited hypoxia, Br J Cancer Suppl, 27, S247
  17. RD Braun, 1999, Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats, Am J Physiol, 277, H551
  18. C Baudelet, 2006, The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors, NMR in biomedicine, 19, 69, 10.1002/nbm.1002 · DOI · Paper page
  19. A Gilead, 1999, Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice, Neoplasia, 1, 226, 10.1038/sj.neo.7900032 · DOI · Paper page
  20. RS Bindra, 2007, Regulation of DNA repair in hypoxic cancer cells, Cancer Metastasis Rev, 26, 249, 10.1007/s10555-007-9061-3 · DOI · Paper page
  21. AX Meng, 2005, Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells, Radiother Oncol, 76, 168, 10.1016/j.radonc.2005.06.025 · DOI · Paper page
  22. SD Young, 1988, Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells, Proc Natl Acad Sci U S A, 85, 9533, 10.1073/pnas.85.24.9533 · DOI · Paper page
  23. AE Greijer, 2004, The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis, J Clin Pathol, 57, 1009, 10.1136/jcp.2003.015032 · DOI · Paper page
  24. MT Santore, 2002, Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells, Am J Physiol Lung Cell Mol Physiol, 282, L727, 10.1152/ajplung.00281.2001 · DOI
  25. RJ Gillies, 2012, Evolutionary dynamics of carcinogenesis and why targeted therapy does not work, Nature reviews, 12, 487
  26. IM Pires, 2010, Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability, Cancer Res, 70, 925, 10.1158/0008-5472.CAN-09-2715 · DOI · Paper page
  27. JP Piret, 2006, Hypoxia protects HepG2 cells against etoposide-induced apoptosis via a HIF-1-independent pathway, Exp Cell Res, 312, 2908, 10.1016/j.yexcr.2006.05.018 · DOI
  28. JP Cosse, 2007, Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines, Mol Cancer, 6, 61, 10.1186/1476-4598-6-61 · DOI
  29. GC Rice, 1986, Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells, Proc Natl Acad Sci U S A, 83, 5978, 10.1073/pnas.83.16.5978 · DOI · Paper page
  30. D Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  31. F Nollet, 1999, The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer, Mol Cell Biol Res Commun, 2, 77, 10.1006/mcbr.1999.0155 · DOI · Paper page
  32. M Kadota, 2010, Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines, PLOS One, 5, e9201, 10.1371/journal.pone.0009201 · DOI · Paper page
  33. JW Wojtkowiak, 2012, Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments, Cancer Res, 72, 3938, 10.1158/0008-5472.CAN-11-3881 · DOI · Paper page
  34. M Brazdova, 2013, Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells, PLOS One, 8, e59567, 10.1371/journal.pone.0059567 · DOI · Paper page
  35. F Vikhanskaya, 2005, Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs, Clin Cancer Res, 11, 4348, 10.1158/1078-0432.CCR-04-1547 · DOI · Paper page
  36. JD Storey, 2003, Statistical significance for genomewide studies, Proc Natl Acad Sci U S A, 100, 9440, 10.1073/pnas.1530509100 · DOI · Paper page
  37. DG Ginzinger, 2000, Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis, Cancer Res, 60, 5405
  38. RA Gatenby, 2004, Why do cancers have high aerobic glycolysis?, Nature reviews, 4, 891
  39. S Yachida, 2013, Evolution and dynamics of pancreatic cancer progression, Oncogene, 18, 29
  40. RJ Gillies, 2008, Causes and consequences of increased glucose metabolism of cancers, J Nucl Med, 49, 24S, 10.2967/jnumed.107.047258 · DOI · Paper page
  41. MW Dewhirst, 2007, Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting, Cancer Res, 67, 854, 10.1158/0008-5472.CAN-06-4744 · DOI · Paper page
  42. A Giatromanolaki, 2001, Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer, Cancer Res, 61, 7992
  43. SK Chia, 2001, Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma, J Clin Oncol, 19, 3660, 10.1200/JCO.2001.19.16.3660 · DOI · Paper page
  44. D Generali, 2006, Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer, Clin Cancer Res, 12, 4562, 10.1158/1078-0432.CCR-05-2690 · DOI · Paper page
  45. AM Jubb, 2010, Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis, J Cell Mol Med, 14, 18, 10.1111/j.1582-4934.2009.00944.x · DOI · Paper page
  46. RJ Gillies, 2007, Hypoxia and adaptive landscapes in the evolution of carcinogenesis, Cancer Metastasis Rev, 26, 311, 10.1007/s10555-007-9065-z · DOI · Paper page
  47. RA Gatenby, 2007, Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer, Br J Cancer, 97, 646, 10.1038/sj.bjc.6603922 · DOI · Paper page
  48. A Ibrahim-Hashim, 2012, Systemic buffers inhibit carcinogenesis in TRAMP mice, J Urol, 188, 624, 10.1016/j.juro.2012.03.113 · DOI
  49. KM Bailey, 2012, Targeting the metabolic microenvironment of tumors, Adv Pharmacol, 65, 63, 10.1016/B978-0-12-397927-8.00004-X · DOI · Paper page
  50. RA Gatenby, 2010, Evolutionary dynamics of cancer prevention, Nature reviews, 10, 526

Cited by

See all 75

Metadata

Authors
Verduzco, D., Lloyd, M., Xu, L., Ibrahim-Hashim, A., Balagurunathan, Y., Gatenby, R. A., & Gillies, R. J.
Venue
PLOS ONE
Published
2015-03-26
Volume
10
Issue
3
Pages
e0120958
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2010469141
Cited by
75
References
9
FWCI
2.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance. https://app.cochat.ai/papers/10.1371/journal.pone.0120958
The paper
Verduzco, D., Lloyd, M., Xu, L., Ibrahim-Hashim, A., Balagurunathan, Y., Gatenby, R. A., & Gillies, R. J. (2015). Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance. PLOS ONE. https://doi.org/10.1371/journal.pone.0120958

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.